<DOC>
	<DOC>NCT01819168</DOC>
	<brief_summary>The aim of this retrospective study is to analyze if nighttime antimuscarincs may be more effective in treating patients with nocturia.</brief_summary>
	<brief_title>Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<criteria>patients who underwent tolterodine SR treatment once per day for 12 weeks in Department of Obstetrics &amp; Gynecology in National Taiwan University Hospital and Far Eastern Memorial Hospital</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>